The International Vaccine Institute (IVI) successfully completed the ‘2022 Introductory Course for Biologics Development and Manufacturing’ on July 29 to train
The International Vaccine Institute (IVI) successfully completed the '2022 Introductory Course for Biologics Development and Manufacturing' on July 29 to train 106 participants from 24 low- and middle-income countries (LMICs) and 32 from the Republic of Korea.